Zobrazeno 1 - 10 of 2 781 pro vyhledávání: '"Sangaletti S"'
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Fracture tailoring in 3D printed continuous fibre composite materials using the Phase field approach for fracture
Autor: Sangaletti, S., García, I.G.
Publikováno v: In Composite Structures 15 November 2022 300
Zobrazit plný text záznamu
5
Akademický článek
Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer.
Autor: Sulsenti R; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Scialpi GB; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Frossi B; Immunology Section, Department of Medicine, University of Udine, Udine, Italy., Botti L; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Ferri R; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Tripodi I; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Piva A; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Sangaletti S; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Pernici D; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Romeo F; Dipartimento di Onologia Sperimentale, European Institute of Oncology IRCCS, Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Lecis D; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Bianchi F; Microenvironment and Biomarkers in Solid tumors Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Fischetti I; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Enriquez C; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Crivelli F; Oncology-Hematology Unit, ASST Valle Olona, Busto Arsizio, Italy., Bregni M; Oncology-Hematology Unit, ASST Valle Olona, Busto Arsizio, Italy., Renne G; Uropathology and Intraoperative Diagnostic Division, European Institute of Oncology IRCCS, Milan, Italy., Pece S; Dipartimento di Onologia Sperimentale, European Institute of Oncology IRCCS, Milan, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Pucillo CE; Immunology Section, Department of Medicine, University of Udine, Udine, Italy., Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Jachetti E; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Publikováno v: Cancer immunology research [Cancer Immunol Res] 2024 Sep 03; Vol. 12 (9), pp. 1147-1169.
Zobrazit plný text záznamu
6
Akademický článek
The EXcellenT Trial: Exercise in Extended Oncogene Addicted Lung Cancer in Active Treatment.
Autor: Bennati C; Oncology Unit, Santa Maria delle Croci Hospital Ravenna, Ravenna, AUSL della Romagna, Italy. Electronic address: chiara.bennati@auslromagna.it., Ferrara R; UniSr, Università Vita-Salute San Raffaele, Milano, Italy., Sangaletti S; Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy., Tamberi S; Oncology Unit, Santa Maria delle Croci Hospital Ravenna, Ravenna, AUSL della Romagna, Italy., Spadoni A; Servizio di Medicina dello Sport, Santa Maria delle Croci Hospital, Ravenna, AUSL della Romagna, Italy., Attisani G; Servizio di Medicina dello Sport, Santa Maria delle Croci Hospital, Ravenna, AUSL della Romagna, Italy., Zanuso S; Technogym Scientific Department, Cesena, Italy., Longobardi J; Oncology Unit, Santa Maria delle Croci Hospital Ravenna, Ravenna, AUSL della Romagna, Italy., Morigi A; Oncology Unit, Santa Maria delle Croci Hospital Ravenna, Ravenna, AUSL della Romagna, Italy., Spreafico M; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola, Italy., Zingaretti C; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola, Italy., Fabbri F; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola, Italy., Carlotti E; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori' (IRST), Meldola, Italy., Fabbri E; Health Services Research, Evaluation and Policy Unit, Local Health Authority of Romagna., Turci L; CRB IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'-IRST S.r.L., D'Arcangelo M; Oncology Unit, Santa Maria delle Croci Hospital Ravenna, Ravenna, AUSL della Romagna, Italy.
Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2024 Jul 15. Date of Electronic Publication: 2024 Jul 15.
Zobrazit plný text záznamu
8
Germinal Center Dark Zone harbors ATR-dependent determinants of T-cell exclusion that are also identified in aggressive lymphoma.
Autor: Cancila V; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Morello G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Bertolazzi G; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; Department of Economics, Business, and Statistics, University of Palermo, Palermo, Italy., Chan AS; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Bastianello G; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Paysan D; Laboratory for Nanoscale Biology, Paul Scherrer Institute, Villigen, Switzerland.; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Jaynes PW; Cancer Science Institute of Singapore, National University of Singapore, Singapore., Schiavoni G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Mattei F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Piconese S; Department of Internal Clinical Sciences, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy.; IRCCS Fondazione Santa Lucia, Unità di Neuroimmunologia, Rome, Italy.; Laboratory affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti, Rome, Italy., Revuelta MV; Division of Hematology and Oncology, Medicine Department, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York., Noto F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., De Ninno A; Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy., Cammarata I; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; Neuroimmunology Unit, IRCCS Fondazione Santa Lucia, Rome, Italy., Pagni F; Department of Medicine and Surgery, Pathology, IRCCS Fondazione San Gerardo dei Tintori, University of Milano-Bicocca, Italy., Venkatachalapathy S; Laboratory for Nanoscale Biology, Paul Scherrer Institute, Villigen, Switzerland., Sangaletti S; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Di Napoli A; Pathology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy., Vacca D; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Lonardi S; Pathology Unit, ASST Spedali Civili di Brescia, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Lorenzi L; Pathology Unit, ASST Spedali Civili di Brescia, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Ferreri AJM; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Belmonte B; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy., Varano G; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Bicciato S; Department of Molecular Medicine, University of Padova, Padova, Italy., Inghirami G; Pathology and Laboratory Medicine Department, Weill Cornell Medicine and New York-Presbyterian Hospital, New York., Cerchietti L; Division of Hematology and Oncology, Medicine Department, Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York., Ponzoni M; Vita-Salute San Raffaele University, Milan, Italy.; Pathology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Zappasodi R; Department of Medicine, Weill Cornell, New York, NY, USA., Facchetti F; Pathology Unit, ASST Spedali Civili di Brescia, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Foiani M; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Casola S; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy., Jeyasekharan AD; Cancer Science Institute of Singapore, National University of Singapore, Singapore.; Department of Haematology-Oncology, National University Health System, Singapore, Singapore.; NUS Centre for Cancer Research, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, University of Palermo, Palermo, Italy.; IFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Publikováno v: Research square [Res Sq] 2024 Mar 18. Date of Electronic Publication: 2024 Mar 18.
Zobrazit plný text záznamu
9
Akademický článek
APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research.
Autor: Prelaj A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy; Electronic, Information e Bio-engeenering, Politecnico di Milano, Milan, Italy., Ganzinelli M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Provenzano L; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. Electronic address: Leonardo.provenzano@istitutotumori.mi.it., Mazzeo L; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Viscardi G; Oncology Department, Ospedale Monaldi, Azienda Ospedaliera Dei Colli, Napoli, Italy., Metro G; Oncology Unit, Azienda Ospedaliera Santa Maria della Misercordia, Perugia, Italy., Galli G; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Agustoni F; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Corte CMD; Dipartimento di Medicina di Precisione, Università degli Studi della Campania 'Luigi Vanvitelli', Napoli, Italy., Spagnoletti A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Giani C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Ferrara R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Proto C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Brambilla M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Dumitrascu AD; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Inno A; Oncology Department, IRCCS Ospedale Sacro Cuore don Calabria, Verona, Italy., Signorelli D; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Pizzutilo EG; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy., Brighenti M; Medical Oncology Unit, ASST Ospedale di Cremona, Cremona, Italy., Biello F; Medical Oncology Unit, Azienda Ospedaliero Universitaria Maggiore della Carità, Novara, Italy., Bennati C; Oncology Unit, Ospedale Santa Maria delle Croci, Ravenna, Italy., Toschi L; Oncology Department, Istituto Clinico Humanitas IRCCS, Milan, Italy., Russano M; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Rome, Italy; Department of Surgery and Cancer, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom., Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, Rome, Italy., Catania C; Oncology Department, Humanitas Gavazzeni, Bergamo, Italy., Bertolini F; Oncology Unit, Modena University Hospital, Modena, Italy., Berardi R; Clinica Oncologica, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Cantini L; Clinica Oncologica, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Pecci F; Clinica Oncologica, Università Politecnica delle Marche, AOU delle Marche, Ancona, Italy., Macerelli M; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Santa Maria Della Misericordia, Udine, Italy., Emili R; Oncology Unit, Ospedale Santa Maria della Misericordia, Urbino, Italy., Bareggi C; Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Verderame F; Oncology Unit, Ospedali Riuniti Villa Sofia Cervello, Potenza, Italy., Lugini A; Oncology Unit, Azienda Ospedaliera San Giovanni Addolorata, Rome, Italy., Pisconti S; Oncology Unit, Ospedale San Giuseppe Moscati, Taranto, Italy., Buzzacchino F; Oncology Unit, Ospedale San Giuseppe Moscati, Taranto, Italy., Aieta M; Oncology Unit, IRCCS CROB, Rionero in Vulture, Italy., Tartarone A; Oncology Unit, IRCCS CROB, Rionero in Vulture, Italy., Spinelli G; UOC Oncologia Territoriale Ausl Latina, Aprilia, Italy., Vita E; Oncology Department, Policlinico Universitario Fondazione 'A.Gemelli' IRCCS, Rome, Italy., Grisanti S; Medical Oncology Unit, ASST Spedali Civili di Breascia, University of Brescia, Brescia, Italy., Trovò F; Electronic, Information e Bio-engeenering, Politecnico di Milano, Milan, Italy., Auletta P; IPOP onlus - Associazione Insieme per i Pazienti di Oncologia Polmonare, Milan, Italy., Lorenzini D; Pathology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Agnelli L; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Sangaletti S; Sperimental Oncology and Molecular Medicine Department, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Mazzoni F; Azienda ospedaliero-universitaria Careggi, Firenze, Italy., Calareso G; Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Ruggirello M; Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Greco GF; Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Vigorito R; Radiology Department, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Occhipinti M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Manglaviti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Beninato T; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Leporati R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Ambrosini P; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Serino R; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Silvestri C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Zito E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Pedrocchi ACL; Electronic, Information e Bio-engeenering, Politecnico di Milano, Milan, Italy., Miskovic V; Electronic, Information e Bio-engeenering, Politecnico di Milano, Milan, Italy., de Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Pruneri G; Pathology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Lo Russo G; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy., Genova C; Medical Oncology Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Vingiani A; Pathology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy.
Publikováno v: Clinical lung cancer [Clin Lung Cancer] 2024 Mar; Vol. 25 (2), pp. 190-195. Date of Electronic Publication: 2023 Dec 22.
Zobrazit plný text záznamu
10
Akademický článek
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion.
Autor: Bassani B; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Simonetti G; Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Cancila V; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, School of Medicine, University of Palermo, 90133 Palermo, Italy., Fiorino A; Predictive Medicine: Molecular Bases of Genetic Risk Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Ciciarello M; CNR Institute of Molecular Genetics 'Luigi Luca Cavalli-Sforza,' Unit of Bologna, Bologna, Italy; IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy; Department of Medical and Surgical Sciences (DIMEC), University of Bologna, Bologna, Italy., Piva A; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Khorasani AM; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Chiodoni C; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Lecis D; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Gulino A; CGT Lab, Cogentech Società Benefit, Catania, Italy., Fonzi E; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori,' Meldola, Forlì-Cesena, Italy., Botti L; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Portararo P; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy., Costanza M; Neuro-Oncology Unit, Department of Clinical Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy., Brambilla M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Colombo G; Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy., Schwaller J; University Children's Hospital Basel & Department of Biomedicine, University of Basel, Basel, Switzerland., Tzankov A; Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland., Ponzoni M; IRCCS Ospedale S. Raffaele, University Vita-Salute San Raffaele, Milan, Italy., Ciceri F; IRCCS Ospedale S. Raffaele, University Vita-Salute San Raffaele, Milan, Italy., Bolli N; Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy., Curti A; Department of Experimental, Diagnostic and Specialty Medicine - DIMES, Institute of Hematology 'Seràgnoli,' Bologna, Italy., Tripodo C; Tumor Immunology Unit, Department of Health Sciences, Human Pathology Section, School of Medicine, University of Palermo, 90133 Palermo, Italy; IFOM-ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Colombo MP; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: mariopaolo.colombo@istitutotumori.mi.it., Sangaletti S; Molecular Immunology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: sabina.sangaletti@istitutotumori.mi.it.
Publikováno v: Cell reports [Cell Rep] 2024 Feb 27; Vol. 43 (2), pp. 113794. Date of Electronic Publication: 2024 Feb 15.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje